{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:51:45Z","timestamp":1793235105427,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"German Centre for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lanmic.2025.101245","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:55:11Z","timestamp":1769514911000},"page":"101245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Artesunate\u2013pyronaridine\u2013atovaquone\u2013proguanil and artesunate\u2013fosmidomycin\u2013clindamycin compared with standard artesunate\u2013pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana"],"prefix":"10.1016","volume":"7","author":[{"given":"Jean Claude Dejon","family":"Agob\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumou","family":"Ma\u00efga-Ascofar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u00f4la Akim","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Pfaffendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Marfo","family":"Boaheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Ronald","family":"Edoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Darko","family":"Agyiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romeo","family":"Bayode Adegbite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esi Yacoba","family":"Bart-Plange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Ahenkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Ekoka Mbassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca Naana","family":"Sarpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Placca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic Kwabena","family":"Kanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wibke","family":"Loag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-7545","authenticated-orcid":false,"given":"Jenny","family":"Kettenbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selidji Todagbe","family":"Agnandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Humphrey","family":"Amuasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rella","family":"Zoleko-Manego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghyslain","family":"Mombo-Ngoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Gottfried","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-1885","authenticated-orcid":false,"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-6327","authenticated-orcid":false,"given":"Johannes","family":"Mischlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101245_bib1","series-title":"WHO Guidelines for Malaria","year":"2023"},{"key":"10.1016\/j.lanmic.2025.101245_bib2","first-page":"990","article-title":"A temporizing solution to \"artemisinin resistance\". Reply","volume":"381","author":"Wang","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101245_bib3","series-title":"Encyclopedia of malaria","first-page":"1","article-title":"Pharmacology of antimalarial drugs, current anti-malarials","author":"Na-Bangchang","year":"2019"},{"key":"10.1016\/j.lanmic.2025.101245_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12936-022-04079-9","article-title":"Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria","volume":"21","author":"Bassat","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101245_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12936-019-2976-7","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against","volume":"18","author":"Krishna","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101245_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003669","article-title":"Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: a single-arm, open-label, cohort event monitoring study","volume":"18","author":"Tona Lutete","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanmic.2025.101245_bib7","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/AAC.00791-16","article-title":"Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria","volume":"60","author":"Stickles","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2025.101245_bib8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","article-title":"Atovaquone and proguanil for Plasmodium falciparum malaria","volume":"347","author":"Radloff","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101245_bib9","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00436-020-06786-1","article-title":"Enhancing the antimalarial activity of artesunate","volume":"119","author":"Adebayo","year":"2020","journal-title":"Parasitol Res"},{"key":"10.1016\/j.lanmic.2025.101245_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0035-9203(00)90447-4","article-title":"The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine","volume":"94","author":"Enosse","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.lanmic.2025.101245_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197638","article-title":"Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors","volume":"13","author":"Sanders","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101245_bib12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2217\/FMB.15.60","article-title":"Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials","volume":"10","author":"Fernandes","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.lanmic.2025.101245_bib13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/430309","article-title":"Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial","volume":"40","author":"Ramharter","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101245_bib14","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/ph15121553","article-title":"Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities","volume":"15","author":"Knak","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.lanmic.2025.101245_bib15","series-title":"Johns Hopkins ABX Guide - clindamycin","author":"Dzintars","year":"2024"},{"key":"10.1016\/j.lanmic.2025.101245_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pt.2009.09.001","article-title":"ABC \u2013 antibiotics-based combinations for the treatment of severe malaria?","volume":"25","author":"Noedl","year":"2009","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.lanmic.2025.101245_bib17","doi-asserted-by":"crossref","first-page":"e1158","DOI":"10.1093\/cid\/ciaa1942","article-title":"Predictive performance of rapid diagnostic tests for falciparum malaria and its modeled impact on integrated community case management of malaria in sub-Saharan African febrile children","volume":"73","author":"Mischlinger","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101245_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/tmi.13124","article-title":"Validity and reliability of methods to microscopically detect and quantify malaria parasitaemia","volume":"23","author":"Mischlinger","year":"2018","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lanmic.2025.101245_bib21","article-title":"Calculating power using Monte Carlo simulations, part 2: running your simulation using power","author":"Huber","year":"2019","journal-title":"The Stata blog: not elsewhere classified"},{"key":"10.1016\/j.lanmic.2025.101245_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.lanmic.2025.101245_bib23","article-title":"Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Pryce","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"10.1016\/j.lanmic.2025.101245_bib24","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1093\/clinids\/6.Supplement_1.S208","article-title":"Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects","volume":"6","author":"George","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101245_bib25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S1473-3099(20)30929-4","article-title":"Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial","volume":"21","author":"Hamaluba","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101245_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(21)00692-7","article-title":"Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial","volume":"22","author":"Peto","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101245_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101245_bib28","series-title":"Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas","year":"2021"},{"key":"10.1016\/j.lanmic.2025.101245_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2022.939291","article-title":"Genomic approaches for monitoring transmission dynamics of malaria: a case for malaria molecular surveillance in sub-Saharan Africa","volume":"2","author":"Mensah","year":"2022","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.lanmic.2025.101245_bib30","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1038\/s41467-023-42030-x","article-title":"Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito","volume":"14","author":"Balta","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2025.101245_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pt.2013.04.001","article-title":"Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy","volume":"29","author":"Krishna","year":"2013","journal-title":"Trends Parasitol"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:46:40Z","timestamp":1773996400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666524725001739"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101245","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate\u2013pyronaridine\u2013atovaquone\u2013proguanil and artesunate\u2013fosmidomycin\u2013clindamycin compared with standard artesunate\u2013pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101245"}}